Alopecia Market Size to Reach USD 14.34 Billion By 2028, Noted Reports and Data

Growing prevalence of various chronic diseases like hyperthyroidism, cancer, rheumatoid arthritis, PCOS, and acute stress disorder, and availability of therapeutic treatments are key factors fueling global market growth 

The global alopecia market size is expected to reach USD 14.34 Billion in 2028 and register a CAGR of 5.1%, according to the latest report by Reports and Data. Key factors such as rising incidences of alopecia areata and androgenetic alopecia, improvements in healthcare infrastructure and technological advancements in treatment are driving global market revenue growth. 

Alopecia is a medical condition seen in men and women which results in hair fall in small patches due to various reasons. Gradual changes in eating patterns, high consumption of unhealthy diet, adoption of sedentary lifestyle, associated stress and aging, hormonal imbalance, high prevalence of genetic and chronic diseases are crucial factors leading to hair fall and baldness. Increasing occurrence of various diseases like cancer, rheumatoid arthritis, PCOS, hyperthyroidism and acute stress disorder, rapidly expanding population part and high consumption of tobacco and alcohol are fueling global market growth. Increasing funding by public and private sectors for ongoing research on alopecia and growing awareness about alopecia and available treatments is also boosting market growth.  

Increasing focus on aesthetic appearance, rapid increase in disposable income, and introduction of various therapeutic drugs are further boosting demand for alopecia treatment across the globe. In addition, many market players are focusing on developing more effective drugs which is expected to boost market growth going ahead. 

However, high cost of treatment, adverse side effects, and unawareness about treatment options especially in some underdeveloped countries are key restraints that are expected to hamper global market growth in the coming years. 

Access Free sample PDF Copy of the Report @

Some key highlights in the report:

  • Among the disease type, the alopecia areata segment accounted for largest market share in 2020 and is expected to maintain its dominant position throughout the forecast period. Alopecia areata is commonly seen in patients suffering from autoimmune diseases. High prevalence of alopecia areata across the world and rising focus on physical appearance and aesthetic appeal are fueling segment revenue growth.
  • The OTC segment is expected to account for rapid revenue growth over the forecast period owing to increasing demand for inexpensive treatment and easy access to therapeutic drugs OTC are supporting market growth. 
  • Among the gender segments, the male segment is expected to account for significant revenue growth between 2021 and 2028. High revenue growth is attributed to factors such as rising incidences of androgenetic alopecia or male pattern hair loss due to various medical conditions, increasing geriatric population, and high intake of tobacco and alcohol.
  • The dermatology clinic is expected to account for significantly high revenue growth over the forecast period owing to increasing number of patients with alopecia, access to transplantation treatments and surgeries, and growing adoption of prescription medicines.  
  • North America is expected to dominate other regional markets in the global alopecia market between 2021 and 2028 owing to increasing prevalence of diseases, introduction of more effective drugs, technological advancements, and well-established healthcare system.
  • Asia Pacific is expected to register for fastest revenue CAGR of 5.4% over the forecast period. Growing awareness about treatment options for alopecia, increase in per capita healthcare expenditure, and high population suffering from alopecia are key factors fueling market growth.  
  • Cipla Inc., Johnson and Johnson AG, Transitions Hair Pty Ltd., Sun Pharmaceutical Industries Ltd., Merck & Co., Inc., Cirrus Hair Centers, Lexington International LLC, Vita-Cos-Med Klett-Loch GmbH, Follica, Inc., and Capillus are some key players operating in the global alopecia market.

Request for Custom Research @

For this study, Reports and Data has segmented the global alopecia market based on disease type, sales channel, end-use, gender, and region:

Disease Type Outlook (Revenue, USD Billion, 2018 - 2028)

  • Alopecia Areata
  • Alopecia Totalis
  • Alopecia Universalis
  • Cicatricial Alopecia
  • Traction Alopecia
  • Androgenetic Alopecia
  • Others

Sales Channel Outlook (Revenue, USD Billion, 2018 - 2028)

  • Prescriptions
  • OTC

End-use Outlook (Revenue, USD Billion, 2018 - 2028)

  • Homecare Settings
  • Dermatology Clinics

Gender Outlook (Revenue, USD Billion, 2018 - 2028)

  • Male
  • Female

Buy now your Exclusive copy of Report @

Regional Outlook (Revenue, USD Billion, 2018 - 2028)

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Rest Of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Rest of LATAM
  • Middle East & Africa
    • Saudi Arabia
    • U.A.E.
    • South Africa
    • Rest of MEA

Explore Reports and Data's Prime Analysis of the global Healthcare & Pharmaceutical Industry:

Cell Therapy Laboratory Equipment Market Size, Share & Growth, By Product, By Application (Cell Processing, Cell Preservation, Distribution & Handling, Process Monitoring & Quality Control) And By Cell Type (Human And Animal Cells) Forecasts To 2027

Consumer Genomics Market Size, Share & Trends, By Product And Services (Consumables, Services, System And Software), By Technology (Sequencing, PCR, Nucleic Acid Extraction And Purification, Microarray, Others), And By Application, And Segment Forecasts To 2027

Veterinary Chemistry Analyzer Market Share, Growth & Analysis, By Product (Instruments, Consumables), By Type (Benchtop, Portable), By Application (Urinalysis, Blood Chemistry Analysis, Others), And By End-Use (Clinical Laboratories, Hospitals), Forecasts To 2027

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:

John W

Head of Business Development

Reports and Data | Web:

Direct Line: +1-212-710-1370


Read Full Press Release:

Back to news